Michael Campbell
Overview
Explore the profile of Michael Campbell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
2116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramalingam K, Woody R, Glencer A, Schwartz C, Mori H, Wong J, et al.
JAMA Oncol
. 2025 Jan;
PMID: 39821301
Importance: Intratumoral immunotherapy that leverages the biological characteristics of high-risk ductal carcinoma in situ (DCIS) may be able to reduce the extent of surgical treatment and provide an alternative approach...
2.
Nie Z, Bonnert R, Tsien J, Deng X, Higgs C, El Mazouni F, et al.
J Med Chem
. 2024 Dec;
68(1):590-637.
PMID: 39710971
Malaria remains a serious global health challenge, yet treatment and control programs are threatened by drug resistance. Dihydroorotate dehydrogenase (DHODH) was clinically validated as a target for treatment and prevention...
3.
Leas D, Keiser J, Charman S, Shackleford D, Jones J, Campbell M, et al.
ACS Infect Dis
. 2024 Oct;
10(11):3963-3972.
PMID: 39423362
Aryl hydantoins were identified in the early 1980s as a promising antischistosomal chemotype. However, as exemplified by Ro 13-3978, this compound series produced antiandrogenic side effects on the host, a...
4.
Liu N, Graves C, Campbell M
Gland Surg
. 2024 Sep;
13(8):1341-1343.
PMID: 39282025
No abstract available.
5.
Lienhardt C, Dooley K, Nahid P, Wells C, Ryckman T, Kendall E, et al.
Bull World Health Organ
. 2024 Jul;
102(8):600-607.
PMID: 39070602
Simpler, shorter, safer and more effective treatments for tuberculosis that are easily accessible to all people with tuberculosis are desperately needed. In 2016, the World Health Organization (WHO) developed target...
6.
Borowsky A, Glencer A, Ramalingam K, Schindler N, Mori H, Ghule P, et al.
Res Sq
. 2024 May;
PMID: 38766192
Ductal carcinoma (DCIS) constitutes an array of morphologically recognized intraductal neoplasms in the mammary ductal tree defined by an increased risk for subsequent invasive carcinomas at or near the site...
7.
Stevenson J, Poker R, Schoss J, Campbell M, Everitt C, Holly B, et al.
Adv Drug Deliv Rev
. 2024 Apr;
209:115322.
PMID: 38677443
Subcutaneous (SC) drug delivery can be a safe, effective alternative to the traditional intravenous route of administration, potentially offering notable advantages for both patients and healthcare providers. The SC Drug...
8.
Piller M, Castilla A, Terragni G, Alozy J, Auffray E, Ballabriga R, et al.
Phys Med Biol
. 2024 Apr;
69(11).
PMID: 38657637
The efficient usage of prompt photons like Cherenkov emission is of great interest for the design of the next generation, cost-effective, and ultra-high-sensitivity time-of-flight positron emission tomography (TOF-PET) scanners. With...
9.
Liu W, Mousa A, Hopkins A, Wu Y, Thu K, Campbell M, et al.
ChemMedChem
. 2024 Apr;
19(16):e202400013.
PMID: 38648251
Metastasis is responsible for about 90 % of cancer deaths. Anti-metastatic drugs, termed as migrastatics, offer a distinctive therapeutic approach to address cancer migration and invasion. However, therapeutic exploitation of...
10.
Wright K, Aagaard N, Ali A, Atuire C, Campbell M, Littler K, et al.
BMC Med Ethics
. 2023 Oct;
24(1):92.
PMID: 37891578
Ethical review systems need to build on their experiences of COVID-19 research to enhance their preparedness for future pandemics. Recommendations from representatives from over twenty countries include: improving relationships across...